3b Blackbio Dx Ltd vs Chandan Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1296 as of 30 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Chandan Healthcare Ltd changed from 20 on March 2025 to 19.8 on March 2026 . This represents a CAGR of -0.50% over 2 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Chandan Healthcare Ltd changed from ₹ 442.58 crore on March 2025 to ₹ 536.48 crore on March 2026 . This represents a CAGR of 10.10% over 2 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Chandan Healthcare Ltd for the Jun '26 is ₹ 82.26 crore as compare to the Mar '26 revenue of ₹ 77.43 crore. This represent the growth of 6.24% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Chandan Healthcare Ltd for the Jun '26 is ₹ 20.98 crore as compare to the Mar '26 ebitda of ₹ 13.32 crore. This represent the growth of 57.51% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Chandan Healthcare Ltd changed from ₹ 4.63 crore to ₹ 7.91 crore over 7 quarters. This represents a CAGR of 35.80% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Chandan Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Chandan Healthcare Ltd

Chandan Healthcare Limited, established on September 03, 2003, specializes in operating state-of-the-art laboratories that offer comprehensive pathological investigations.
The Company run a diagnostic network in North India with pathology and radiology testing services.
Their services encompass biochemistry, hematology, histopathology, microbiology, and immunology.
Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The Company commenced business by starting its first diagnostic centre in Indra Nagar, Lucknow in 2003.
Later, it started the diagnostic centre in Dehradun in 2013.

FAQs for the comparison of 3B Blackbio DX Ltd and Chandan Healthcare Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Chandan Healthcare Ltd?

Market cap of 3B Blackbio DX Ltd is 1,112 Cr while Market cap of Chandan Healthcare Ltd is 574 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Chandan Healthcare Ltd?

The stock performance of 3B Blackbio DX Ltd and Chandan Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Chandan Healthcare Ltd?

As of October 31, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1296.25. On the other hand, Chandan Healthcare Ltd stock price is INR ₹235.0.

How do dividend payouts of 3B Blackbio DX Ltd and Chandan Healthcare Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Chandan Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.